All Stories

  1. Tetrazolo[1,5-c]quinazolines as anti-Klebsiella pneumoniae scaffolds: Bridging in vitro activity and multi-target docking prediction
  2. Prospects for the use of 3-R-benzo[f][1,2,4]triazino[2,3-d][1,4]diazepine-2,7(6H,8H)-diones as agonists and antagonists of GABAA receptors
  3. BENZO[f][1,2,4]TRIAZINO[2,3-d][1,4]DIAZEPINES – A NEW HETEROCYCLIC SYSTEM: SYNTHESIS AND SPECTRAL CHARACTERISTICS
  4. Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo Evaluation
  5. Новітні підходи до організації та проведення навчальної практики для студентів хімічних спеціальностей
  6. Initial Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo Evaluation
  7. In Silico Identification and Characterization of Spiro[1,2,4]triazolo[1,5-c]quinazolines as Diacylglycerol Kinase α Modulators
  8. The Application of S-Substituted Pteridine for CCl4-Induced Acute Hepatitis Treatment in Rats
  9. Application of S‐Substituted Pteridine for Acute Hepatitis Treatment in Rats
  10. Search for Potential Neuroprotectors for Correction of Cognitive and Behavioral Disorders After Ketamine Anesthesia Among 2′-R-6’H-Spiro(cycloalkyl-, heterocyclyl)[1,2,4]triazolo[1,5-<em>c</em>]Quinazolines: Fragment-Oriented Design, Molecu...
  11. In Silico Identification and Characterization of Spiro [1,2,4]triazolo[1,5-<i>c</i>]quinazolines as Diacylglycerol Kinase α Modulators
  12. Search for Potential Neuroprotectors for Correction of Cognitive and Behavioral Disorders After Ketamine Anesthesia Among 2′-R-6’H-Spiro(cycloalkyl-, heterocyclyl)[1,2, 4]triazolo[1,5-C]-Quinazolines: Fragment-Oriented Design, Molecular Docking, ADMET,...
  13. Antistaphylococcal Triazole-Based Molecular Hybrids: Design, Synthesis and Activity
  14. [1,2,4]triazino[2,3-c]quinazoline hybrids with azole and azine heterocycles: design, synthesis, antibacterial and antiradical activity
  15. [2-(3-R-1H-[1,2,4]-Triazol-5-YL)Phenyl]Amines: Design, Synthesis and Assessment of Their Anti-Staphylococcal Potential
  16. Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-c]quinazolines Against Nakaseomyces glabrata: Integrating In Vitro Studies, Molecular Docking, QSAR, and In Silico Toxicity Assessments
  17. Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolines
  18. Combating <i>Candida glabrata</i>: Screening 5,6-Dihydrotetrazolo[1,5-<i>c</i>]Quinazolines through <i>In Vitro</i> Studies, Molecular Docking, QSAR and Toxicity Assessments
  19. Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2, 4]triazino[2,3-C]quinazolines
  20. Influence of substituted quinones on the excretory function of the rat kidney and evaluation of the prospects of their use as potential diuretics
  21. МЕТОДИ СИНТЕЗУ ХІНАЗОЛІНІВ ТА ЇХ КОНДЕНСОВАНИХ ПОХІДНИХ – ПОТЕНЦІЙНИХ ПРОТИЗАПАЛЬНИХ АГЕНТІВ (ОГЛЯД)
  22. ПОШУК НОВИХ ІНГІБІТОРІВ ТИРОЗИНКІНАЗИ СЕРЕД 2-(3-R-1H-1,2,4-ТРИАЗОЛ-5-ІЛ)АНІЛІНІВ ЯК ПОТЕНЦІЙНИХ ПРОТИПУХЛИННИХ АГЕНТІВ З ВИКОРИСТАННЯМ МОЛЕКУЛЯРНОГО ДОКІНГУ
  23. N-arylsulfonyl-2-aroylamino-1,4-quinone imines and their hydrogenated analogues: prediction of toxicity and prospects for use as diuretics
  24. 5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives
  25. Evaluation of the toxicity and hepatoprotective properties of new s-substituted pteridins
  26. Tacrolimus and Azole Derivatives of Agricultural and Human Health Importance: Prediction of ADME Properties
  27. Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase
  28. Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology
  29. In silico and in vivo screening of triamterene synthetic analogues as promising diuretics
  30. Тhio‐containing pteridines: Synthesis, modification, and biological activity
  31. ПОКРОКОВА МЕТОДИКА ВИЗНАЧЕННЯ МІНІМАЛЬНОЇ ІНГІБУЮЧОЇ КОНЦЕНТРАЦІЇ ГІДРОФОБНОЇ БІОЛОГІЧНО-АКТИВНОЇ СПОЛУКИ МЕТОДОМ РОЗВЕДЕННЯ З БУЛЬЙОНОМ
  32. Directed search for diuretics among 6-substituted pteridine-2,4,7(1H,3H,8H)-triones
  33. MOLECULAR DOCKING OF 5-PHENYL-5,6-DIHYDROTETRAZOLO- [1,5-c]QUINAZOLINES TO PENICILLIN-BINDING PROTEIN 2X (PBP 2X) AND PRELIMINARY RESULTS OF ANTIFUNGAL ACTIVITY
  34. ADME PROPERTIES PREDICTION OF 5-PHENYL-5,6-DIHYDROTETRAZOLO[1,5-c] QUINAZOLINES
  35. MOLECULAR DOCKING OF 5-PHENYL-5,6-DIHYDROTETRAZOLO-[1,5-c]QUINAZOLINES TO RIBOSOMAL 50S PROTEIN L2P (2QEX)
  36. Concepts for New Rapid Simple HPLC Method for Quantification of Fosfomycin Trometamol in Pharmaceutical Dosage Forms with Direct UV Detection
  37. Substituted acyl thioureas and acyl thiosemicarbazides: synthesis and biological activity (minireview)
  38. Heterocyclizations based on N-(R-hydrazine-1-carbonothioyl)cycloalkancarboxamides: functionalized azoles and their antimicrobial activity
  39. Carboxyl-containing quinazolines and related heterocycles as carriers of anti-inflammatory activity
  40. CИНТЕЗ ФІЗИКО-ХІМІЧНІ ВЛАСТИВОСТІ, АНТИМІКРОБНА ТА АНТИРАДИКАЛЬНА АКТИВНІСТЬ ЗАМІЩЕНИХ БЕНЗО[4,5]ІМІДАЗО[1,2-с]ХІНАЗОЛІН-6(5H)-ОНІВ (-ТИОНІВ)
  41. MOLECULAR DOCKING OF [1,2,4]TRIAZOLO [1,5-c]QUINAZOLINES TO SARS-CoV-2 NON-STRUCTURAL PROTEIN 3 MACRODOMAIN (6YWM)
  42. Chiral Monolithic Silica-Based HPLC Columns for Enantiomeric Separation and Determination: Functionalization of Chiral Selector and Recognition of Selector-Selectand Interaction
  43. ANTI-TUMOR POTENTIAL OF SUBSTITUTED 6-OXO(THIOXO)-6,7- DIHYDRO-2Н-[1,2,4]TRIAZINO[2,3-С]QUINAZOLIN-2-ONES
  44. Conformational polymorphs of 3-cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-1,2,4-oxadiazole
  45. 2-Сycloalkyl-(hetaryl-)-[1,2,4]triazol[1,5-с]quinazolines: synthesis, physical and chemical properties and antibacterial activity
  46. Synthesis, antimicrobial, and mitotic toxicity evaluation of new 6‐substituted 2‐(benzo[4,5]imidazo[1,2‐ c ]quinazolin‐5( 6 H )‐yl)acetic...
  47. A Novel Series of [1,2,4]Triazolo[4,3-a]Pyridine Sulfonamides as Potential Antimalarial Agents: In Silico Studies, Synthesis and In Vitro Evaluation
  48. Concomitant polymorphic forms of 3-cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
  49. Novel N ‐Cycloalkylcarbonyl‐ N ′‐arylthioureas: Synthesis, Design, Antifungal Activity and Gene Toxicity
  50. 2-[(3-Aminoalkyl-(alkaryl-,aryl-))-1H-1,2,4-triazol-5-yl]anilines: synthesis and anticonvulsant activity
  51. Synthesis and structure of pyrido[1,2-a]quinazoline condensed derivatives
  52. Substituted 3-R-2,8-Dioxo-7,8-dihydro-2H-pyrrolo[1,2-a][1,2,4]triazino-[2,3-c]quinazoline-5a(6H)carboxylic Acids and Their Salts – a Promising Class of Anti-inflammatory Agents
  53. Directed Search of Anti-inflammatory Agents Among (3HQuinazoline- 4-ylidene)hydrazides of N-protected Amino acids and their Heterocyclization Products
  54. ЗАМІЩЕНІ 3-R-7,8-ДИГІДРО-2Н-ПІРОЛО[1,2-а][1,2,4]ТРИАЗИНО[2,3-с]ХІНАЗОЛІН-5а(6Н)-АЛКІЛКАРБОНОВІ КИСЛОТИ – ПЕРСПЕКТИВНИЙ КЛАС МАЛОТОКСИЧНИХ ПРОТИЗАПАЛЬНИХ АГЕНТІВ
  55. Synthesis and mode of action studies of novel {2‐(3‐R‐1H‐1,2,4‐triazol‐5‐yl)phenyl}amines to combat pathogenic fungi
  56. Amides of substituted 3-(pteridin-6-yl)propanoic acids: synthesis, spectral characteristics, and cytotoxic activity
  57. Synthesis of 7-arylimidazo[1,2-a]pyrazin-8(7H)-one derivatives
  58. Synthesis, Modification, and Anticonvulsant Activity of 3′‐R1‐Spiro[indoline‐3,6′‐[1,2,4]triazino[2,3‐c]quinazolin]‐2,2′(7′H)‐diones Derivatives
  59. Directed Search of Biologically Active Compounds among Hydrogenated Isoindolylalkyl(alkylaryl-,aryl-)carboxylic Acids with Quinazoline Fragment that Modify the Carbohydrate Metabolism: Design, Synthesis and Modification
  60. Novel acyl thiourea derivatives: Synthesis, antifungal activity, gene toxicity, drug-like and molecular docking screening
  61. [1,2,4]Triazino[2,3-с]quinazolines 3*. Structure and anticancer activity of products obtained from reaction of 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones with aryl iso(thio)cyanates
  62. 2-([1,2,4]triazolo[1,5-c]quinazoline-2-yl-)alkyl-(alkaryl-,aryl-)-amines and their derivatives. Message 2. The synthesis of (3Н-quinazoline-4-ylidene)hydrazides N-protected aminoacids, using a variety of amine-protecting approaches. Physical-chemical prop
  63. Trіazolo[1,5-c]quіnazolіnes Synthesis, antimicrobial and antifungal activity [quinazolin-4(3H)-ylidene]hydrazides of carboxylic acids (Message 1)
  64. Synthesis, Tautomerism, and Antiradical Activity of Novel Pteridinetrione Derivatives
  65. Design, Synthesis and Anti-inflammatory Activity of Derivatives 10-R-3-Aryl-6,7-dihydro-2H-[1,2,4] triazino[2,3-c]quinazolin-2-ones of Spiro-fused Cyclic Frameworks
  66. Synthesis and Hypolipidemic Activity of New 6,6-Disubstituted 3-R-6,7-Dihydro-2H -[1,2,4]triazino[2,3-c ]quinazolin-2-Ones
  67. [1,2,4]Triazino[2,3-с]quinazolines 2*. Synthesis, structure, and anticonvulsant activity of new 3′-R1-spiro[(aza/oxa/thia)cycloalkyl-1(3, 4),6′-[1,2,4]triazino[2,3-c]quinazolin]-2′(7′H)-ones
  68. [1,2,4]Triazino[2,3-с]quinazolines 1. Methods for the preparation and spectral characteristics of substituted 3-R1-6-R3-6,7-dihydro-2H-[1,2,4]triazino[2,3-с]quinazolin-2-ones
  69. 3'-R-Spiro[cycloalkyl-1(2), (hetaryl-3(4), 6'-[1,2,4]triazino[2,3-c]quinazoline]-2'(7'H)-2-оnes as a perspective class of compounds with actoprotective activity
  70. 2-(Azolyl)anilines: methods of synthesis, cyclocondensations, and biological properties
  71. Preparation and biological properties of 2-thio-containing pyrimidines and their condensed analogs
  72. Dimethyl Acetylenedicarboxylate in Reactions with Substituted 3-(2-aminophenyl)-6-R1 -1,2,4-triazin-5-(2H )-ones: Structure and Properties of the Products
  73. Origin of Substituent Effect on Tautomeric Behavior of 1,2,4-Triazole Derivatives: Combined Spectroscopic and Theoretical Study
  74. Potential of N-aryl(benzyl,heteryl)-2-(tetrazolo[1,5-c]quinazolin-5-ylthio)acetamides as anticancer and antimicrobial agents
  75. 2-([1,2,4]triazolo[1,5-c]quinazolin-2-yl-)alkyl-(alkaryl-, aryl-)-amines and their derivatives. (3Н-quinazolin-4-yliden)hydrazides (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)alkyl-(alkaryl-, aryl-)carboxylic acids: features of synthesis, modification and ant
  76. Synthesis of 6-N-R-Tetrazolo[1,5-c]quinazolin-5(6H)-ones and Their Anticancer Activity
  77. Synthesis and Characterization of Novel N‐(Phenyl, Benzyl, Hetaryl)‐2‐([1,2,4]Triazolo[1,5‐c]Quinazolin‐2‐ylthio)Acetamides by Spectral Data, Antimicrobial Activity, Molecular Docking and QSAR Studies
  78. Synthesis, Anticancer, and QSAR Studies of 2-Alkyl(aryl,hetaryl)quinazolin-4(3H)-thione's and [1,2,4]Triazolo[1,5-c]quinazoline-2-thione's Thioderivatives
  79. Dimroth rearrangement in the synthesis of substituted cyclopentaand cyclohexa[4,5]thieno[2',3':4,5]pyrimido[1,6-b][1,2,4]triazines
  80. Benzo[e][1,2,4]triazino[2,3-c][1,2,3]triazin-2-ones electro-deficient heterocyclic compounds with promising anticancer activity
  81. Investigation of actoprotective activity in a range of 6-N-R-tetrazolo[1,5-c]quinazolin-5(6H)-ones
  82. Spectrophotometric determination of original active pharmaceutical ingredient Quinabut and tablets based on it
  83. 1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities
  84. Synthesis and hydrolytic cleavage of tetrazolo[1,5-c]quinazolines
  85. Search for Compounds with Hypoglycemic Activity in the Series of 1-(2-(1H-Tetrazol-5-yl)-R1-Phenyl)-3-R2-phenyl(ethyl)ureas and R1-Tetrazolo[1,5-c]quinazolin-5(6H)-ones
  86. Novel approach for the synthesis of N-unsubstituted 2,3,5,6-tetrahydro-4H-2,6-methano-1,3-benzoxazocine-4-thiones
  87. Interaction of 3-(2-Aminophenyl)-6-R1-1,2,4-triazin-5-ones with Acylating Reagents: An Efficient Method for Preparation of 6-Substituted 3-R1-2H-[1,2,4]triazino[2,3-c]quinazolin-2-ones
  88. 2-Alkyl(aryl)-quinazolin-4(3H)-thiones, 2-R-(quinazolin-4(3H)-ylthio)carboxylic acids and amides: synthesis, molecular docking, antimicrobial and anticancer properties
  89. 2‐Heteroaryl‐[1,2,4]triazolo[1,5‐c]quinazoline‐5(6 H)‐thiones and Their S‐Substituted Derivatives: Synthesis, Spectroscopic Data, and Biological Activity
  90. Formation of 1-methyl[1,2,4]triazolo[4,3-a] quinazolin-5(4H)-ones by reaction of 2-hydrazinoquinazolin-4(3H)-ones with acetylacetone
  91. Таутомерія 4-гідразинохіназолінів, коливальні спектри та комп'ютерне моделювання
  92. Hydrazinolysis of 3- R -[1,2,4]Triazino[2,3-c]quinazolin-2-ones. Synthetic and Theoretical Aspects
  93. Reaction of 4-chloroquinazoline with arenesulfonothioic acid salts
  94. Design and Evaluation of Novel Antimicrobial and Anticancer Agents Among Tetrazolo[1,5-c]quinazoline-5-thione S-Derivatives
  95. Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)[1,2,4]triazolo[1,5-c]quinazolines
  96. Novel N-aryl(alkaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides: synthesis, cytotoxicity, anticancer activity, COMPARE analysis and docking
  97. Substituted 2-[(2-Oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thio]acetamides with Thiazole and Thiadiazole Fragments: Synthesis, Physicochemical Properties, Cytotoxicity, and Anticancer Activity
  98. Synthesis of New 6-{[ω-(Dialkylamino(heterocyclyl)alkyl]thio}-3-R-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones and Evaluation of their Anticancer and Antimicrobial Activities
  99. Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides
  100. Synthesis, Cytotoxicity by Bioluminescence Inhibition, Antibacterial and Antifungal Activity of ([1,2,4]Triazolo[1,5-c]quinazolin-2-ylthio)carboxylic Acid Amides
  101. Synthesis of spiro-fused (C5)-pyrazolino-(C6)-triazinones, a new heterocyclic system
  102. Synthesis of New 2-Thio-[1,2,4]triazolo[1,5-c]quinazoline Derivatives and Its Antimicrobial Activity
  103. Synthesis of 5-Hydroxymethyl-8-methyl-3-(3-aryl-[1,2,4]oxadiazol-5-yl)-2H-pyrano[2,3-c]pyridin-2-ones and Their Esters
  104. 5-(3,4-Dimethylphenylsulfonyl)-8-methoxy-2-methyl-2,3,5,6-tetrahydro-4H-2,6-methano-1,3-benzoxazocin-4-one
  105. Novel Method for the Synthesis of [1,2,4]Triazino[4,3‐c]quinazoline System
  106. An Efficient and Convenient Synthesis of 2-Thio[1,2,4]triazolo[1,5-c]quinazoline and its Derivatives
  107. SYNTHESIS OF NEW 3-SUBSTITUTED DERIVATIVES OF 7-AZACOUMARINES